Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05029362 · ClinicalTrials.gov registry record · NA

SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups

A NA study of Smoking Cessation, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT05029362 is a NA study of Smoking Cessation that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 18 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05029362, a NA study of Smoking Cessation, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to pretest the design of a text-based smoking cessation program tailored to sexual minority individuals.

Conditions Studied

Interventions

  • BEHAVIORAL SmokefreeSGM

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2022-01-05
Est. Completion 2022-10-05
Phase NA

What the Registry Record Tells You About NCT05029362

The ClinicalTrials.gov registry entry for NCT05029362 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (96% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which SmokefreeSGM is the first listed.

NCT05029362 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05029362 about?

NCT05029362 is a clinical study titled "SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups". The purpose of this study is to pretest the design of a text-based smoking cessation program tailored to sexual minority individuals.

What is the current status of trial NCT05029362?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-01-05. Estimated completion is 2022-10-05.

What conditions does trial NCT05029362 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT05029362?

The interventions under investigation include: SmokefreeSGM (BEHAVIORAL).

Who is sponsoring clinical trial NCT05029362?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05029362 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.